Literature DB >> 22535475

Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm.

Nikhil D Thawal1, Ajinkya B Yele, Praveen K Sahu, Balu A Chopade.   

Abstract

Biofilm formation in Acinetobacter baumannii is a common cause of nosocomial infections in humans. Clinical devices and abiotic surfaces are important sites of colonization leading to formation of biofilms. Such infections are often resistant to multiple antibiotic therapies, and hence there is need for an effective mode of control. Herein, we describe the isolation, characterization of a new lytic bacteriophage of A. baumannii and its effect on biofilm. The phage AB7-IBB2, with a genome size of about 170 kb was identified to be of family Podoviridae as revealed by transmission electron microscopy. It had an isometric head (35 nm) and a short tail (7 nm). It lysed 19/39 (49 %) clinical isolates of A. baumannii. Rapid adsorption (>99 % adsorbed in 4 min), a latency period of 25 min and a burst size 22 PFU/infected cell was observed. The phage could inhibit A. baumannii biofilm formation and disrupt preformed biofilm as well. The phage has promising potential to be considered as a candidate biocontrol agent for A. baumannii infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535475     DOI: 10.1007/s00284-012-0127-2

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  30 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 2.  The interaction of phage and biofilms.

Authors:  Ian W Sutherland; Kevin A Hughes; Lucy C Skillman; Karen Tait
Journal:  FEMS Microbiol Lett       Date:  2004-03-12       Impact factor: 2.742

3.  Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital.

Authors:  Stephen J Wilson; Cynthia J Knipe; Madeline J Zieger; Kari M Gabehart; Joyce E Goodman; Helen M Volk; Rajiv Sood
Journal:  Am J Infect Control       Date:  2004-10       Impact factor: 2.918

4.  "Escherichia coli-milk" biofilm removal from stainless steel surfaces: synergism between ultrasonic waves and enzymes.

Authors:  Nadia Oulahal-Lagsir; Adele Martial-Gros; Marc Bonneau; Loic J Blum
Journal:  Biofouling       Date:  2003-06       Impact factor: 3.209

Review 5.  Clinical impact and pathogenicity of Acinetobacter.

Authors:  M-L Joly-Guillou
Journal:  Clin Microbiol Infect       Date:  2005-11       Impact factor: 8.067

6.  Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?

Authors:  Anna de Breij; Lenie Dijkshoorn; Ellen Lagendijk; Joke van der Meer; Abraham Koster; Guido Bloemberg; Ron Wolterbeek; Peterhans van den Broek; Peter Nibbering
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Lytic infection of Escherichia coli biofilms by bacteriophage T4.

Authors:  M M Doolittle; J J Cooney; D E Caldwell
Journal:  Can J Microbiol       Date:  1995-01       Impact factor: 2.419

9.  Plasmid mediated silver resistance in Acinetobacter baumannii.

Authors:  L M Deshpande; B A Chopade
Journal:  Biometals       Date:  1994-01       Impact factor: 2.949

10.  Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A.

Authors:  Sanna Sillankorva; Peter Neubauer; Joana Azeredo
Journal:  BMC Biotechnol       Date:  2008-10-27       Impact factor: 2.563

View more
  11 in total

1.  Genomic and Biochemical Characterization of Acinetobacter Podophage Petty Reveals a Novel Lysis Mechanism and Tail-Associated Depolymerase Activity.

Authors:  A C Hernandez-Morales; L L Lessor; T L Wood; D Migl; E M Mijalis; J Cahill; W K Russell; R F Young; J J Gill
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

2.  Characterization and Detection of Endolysin Gene from Three Acinetobacter baumannii Bacteriophages Isolated from Sewage Water.

Authors:  Thawatchai Kitti; Rapee Thummeepak; Aunchalee Thanwisai; Kamala Boonyodying; Duangkamol Kunthalert; Pannika Ritvirool; Sutthirat Sitthisak
Journal:  Indian J Microbiol       Date:  2014-05-21       Impact factor: 2.461

3.  In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.

Authors:  Jongsoo Jeon; Choong-Min Ryu; Jun-Young Lee; Jong-Hwan Park; Dongeun Yong; Kyungwon Lee
Journal:  Appl Environ Microbiol       Date:  2016-06-30       Impact factor: 4.792

Review 4.  Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.

Authors:  Stephen T Abedon
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-09

Review 5.  Nanoparticles for Control of Biofilms of Acinetobacter Species.

Authors:  Richa Singh; Shradhda Nadhe; Sweety Wadhwani; Utkarsha Shedbalkar; Balu Ananda Chopade
Journal:  Materials (Basel)       Date:  2016-05-18       Impact factor: 3.623

Review 6.  Inhibition of Virulence Factors and Biofilm Formation of Acinetobacter Baumannii by Naturally-derived and Synthetic Drugs.

Authors:  Nilushi Indika Bamunuarachchi; Fazlurrahman Khan; Young-Mog Kim
Journal:  Curr Drug Targets       Date:  2021       Impact factor: 2.937

Review 7.  Phage therapy: eco-physiological pharmacology.

Authors:  Stephen T Abedon
Journal:  Scientifica (Cairo)       Date:  2014-05-20

8.  Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates.

Authors:  Fan Peng; Zhiqiang Mi; Yong Huang; Xin Yuan; Wenkai Niu; Yahui Wang; Yuhui Hua; Huahao Fan; Changqing Bai; Yigang Tong
Journal:  BMC Microbiol       Date:  2014-07-05       Impact factor: 3.605

9.  Genomic analysis reveals high virulence and antibiotic resistance amongst phage susceptible Acinetobacter baumannii.

Authors:  Udomluk Leungtongkam; Rapee Thummeepak; Thawatchai Kitti; Kannipa Tasanapak; Jintana Wongwigkarn; Kathryn M Styles; Elizabeth M H Wellington; Andrew D Millard; Antonia P Sagona; Sutthirat Sitthisak
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

Review 10.  Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.

Authors:  Zahra Chegini; Amin Khoshbayan; Majid Taati Moghadam; Iman Farahani; Parham Jazireian; Aref Shariati
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-30       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.